Ameloblastoma screening: Difference between revisions
Jump to navigation
Jump to search
(Category) |
No edit summary |
||
| (3 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Ameloblastoma}} | {{Ameloblastoma}} | ||
{{CMG}}{{AE}}{{ | {{CMG}} ; {{AE}} {{VKG}} | ||
==Overview== | ==Overview== | ||
According to the United States Preventive Services Task Force, screening for ameloblastoma is not recommended. | According to the [[USPSTF|United States Preventive Services Task Force]], [[Screening (medicine)|screening]] for ameloblastoma is not recommended. | ||
==Screening== | ==Screening== | ||
According to the [[United states preventive services task force recommendations scheme|United States Preventive Services Task Force]], [[Screening (medicine)|screening]] for ameloblastoma is not recommended. | |||
==References== | ==References== | ||
Latest revision as of 18:44, 23 October 2019
|
Ameloblastoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Ameloblastoma screening On the Web |
|
American Roentgen Ray Society Images of Ameloblastoma screening |
|
Risk calculators and risk factors for Ameloblastoma screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]
Overview
According to the United States Preventive Services Task Force, screening for ameloblastoma is not recommended.
Screening
According to the United States Preventive Services Task Force, screening for ameloblastoma is not recommended.